Search results for: Determining Value
Filter search results
The case for adopting a broader perspective on value in Health Technology Assessment
3 March 2026
…to invest in the collection of such data until HTA bodies confirm their willingness to adopt a broader perspective in their appraisals. Incorporating broader value elements will increase value-based prices…
Assessing the Life-cycle Value of Second-generation Antipsychotics in Sweden and the UK
17 July 2019
…the entire life-cycle, the value added by SGAs to the system is higher than the expected value estimated at launch. P&R decisions should consider the value added by medicines over…
The value of cell and gene therapies to the UK economy
20 October 2025
…of value within a 10-year time horizon. For example, the value of CGTs to individuals with AML is £578 million, driven primarily by health gains. Meanwhile, the most significant value…
A US Approach to a Framework for Payer Assessment of New Technologies
22 September 2014, 11:00pm
Payers in the US do not embrace a single, dominant method for determining the value of new technologies. With this mind, Dr Steven Pearson has convened a US policy workgroup…
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
…conceptual idea of “value” into two components, clinical care value and health system value. Judgements as to the clinical care value of drugs and devices are based on five elements:…
Reflections from Adrian Towse on decades of HEOR research and impact
11 November 2025
…that in my writing. We need a theoretical framework when we consider broadening frameworks of value. Otherwise, we end up with an ad hoc collection of elements of value with…
Compared to what? How the choice of comparator affects new medicines
14 September 2026
…on the comparator: the comparator’s own cost and effectiveness define the origin from which incremental value is measured, and therefore the benchmark the new treatment must beat. Comparators vary substantially…
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…into clinical development strategies. Policy makers and payer decision-makers should expand value frameworks used in HTA to integrate broader value dimensions, fostering a comprehensive evaluation of the full value of…
5 Things You Should Do with EQ-5D Data
29 January 2016
…need to use a value set to summarise your EQ-5D data – e.g., for estimating QALYs – make sure you do sensitivity analysis to alternative value sets. Value sets are…